The effects of aging on tumor growth and angiogenesis are tumor‐cell dependent
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
It is generally accepted that histologically similar tumors grow more slowly, with less angiogenesis, in aged mice relative to young mice. We subcutaneously implanted TRAMP‐C2 tumor cells, a prostate cancer cell line not previously examined in aging, into syngeneic C57/Bl6 young (4 month) and aged (20 month) mice and compared tumor growth and angiogenesis. Unexpectedly, the prostate tumors grew as fast in aged as in young mice. Angiogenesis in TRAMP‐C2 tumors was robust, with no differences between the young and aged mice in the number of vessels, distribution of vessel sizes or features of vessel maturation. Aged mice had lower levels of serum testosterone than the young mice. VEGF levels were similar in the tumors and sera of the young and aged mice. Comparison with B16/F10 melanoma, a cancer cell line that is representative of previous studies in aged mice, showed that B16/F10 tumors grew minimally in the aged mice. In contrast to the B16/F10, TRAMP‐C2 tumors had an extracellular matrix with significantly higher levels of MMP2 and MMP9 expression and activity. These unique results demonstrate that tumor progression can be as robust in aged tissues as young tissues. The ability of aged mice to grow large, vascularized prostate tumors is associated with high levels of MMP2/9 activity that may produce a permissive environment for tumor growth and angiogenesis. These data demonstrate that tumor‐cell specific features determine the effect of aging on tumor growth and angiogenesis. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
DePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951
Cancer and ageing: a nexus at several levels
Balducci, L., & Ershler, W. B. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1675 · Cited by 250
Histopathology of breast cancer in relation to age
Fisher, C., Egan, M., Smith, P., Wicks, K., Millis, R., & Fentiman, I. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.103 · Cited by 164 · cited 1×
“At least 2 observational studies have noted reduced numbers of blood vessels, independent of tumor cell characteristics, in the breast cancers of aged women compared to young women.(20,21) Although the connections between patient age, tumor vessel density, growth rate and clinical outcomes are still being established,…”
BackgroundCalabrese, C. T., Adam, Y. G., & Volk, H. (1973) · The American Journal of Surgery · doi:10.1016/0002-9610(73)90024-x · Cited by 55
Cited by
How ageing processes influence cancer
de Magalhães, J. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3497 · Cited by 367
Two-Step Senescence-Focused Cancer Therapies
Sieben, C. J., Sturmlechner, I., van de Sluis, B., & van Deursen, J. M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.04.006 · Cited by 222
Cancer prevalence and mortality in centenarians: a systematic review
Pavlidis, N., Stanta, G., & Audisio, R. A. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.09.007 · Cited by 115
Gao, P., Shen, F., Gabriel, R. A., Law, D., Yang, E. Y., Yang, G.-Y., Young, W. L., & Su, H. (2009) · Stroke · doi:10.1161/strokeaha.109.561050 · Cited by 66
Sekido, K., Tomihara, K., Tachinami, H., Heshiki, W., Sakurai, K., Moniruzzaman, R., Imaue, S., Fujiwara, K., & Noguchi, M. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.104462 · Cited by 23
Metadata
- Authors
- Reed, M. J., Karres, N., Eyman, D., Cruz, A., Brekken, R. A., & Plymate, S.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-12-27
- Volume
- 120
- Issue
- 4
- Pages
- 753-760
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1986111527
- Cited by
- 53
- References
- 5
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.